Description The purpose of this best practice advice (BPA) article from the Clinical Practice
Update Committee of the American Gastroenterological Association is to provide an update …

The care of patients with oesophageal cancer or of individuals who have an elevated risk of
oesophageal cancer has changed dramatically. The epidemiology of squamous cell and …

Barrett's esophagus (BE) is a common condition associated with chronic gastroesophageal
reflux disease. BE is the only known precursor to esophageal adenocarcinoma, a highly …

Background & aims Ten percent of patients with an upper gastrointestinal cancer will have
received an esophagogastroduodenoscopy (EGD) within 3 years before diagnosis, termed …

Abstract Background and Aims Endoscopic eradication therapy for Barrett's esophagus (BE)-
related neoplasia is increasingly being performed at tertiary and community centers. While it …

Endoscopic surveillance of Barrett's esophagus, aiming to detect prevalent dysplasia and
adenocarcinoma, followed by effective endoscopic treatment, is an integral part of the …

The group agreed to define 2 terms for BE-related neoplasia after index endoscopy: include
EAC only (PEEC) and include both HGD and EAC (postendoscopy esophageal neoplasia …

Breath analysis, despite being an overlooked biomatrix, has a rich history in disease
diagnosis. However, volatile organic compounds (VOCs) have yet to establish themselves …

Summary Background The Coronavirus pandemic (COVID-19) curtailed endoscopy
services, adding to diagnostic backlogs. Building on trial evidence for a non-endoscopic …

Over the past few decades, the rates of esophageal adenocarcinoma (EAC) in the USA
continue to increase, particularly in adults≥ 65 years old (Fig. 1)[1]. Barrett's esophagus …